Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | PPARD | Q03181 | 2/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GABRP | O00591 | 1/20 | 0.33 |
| ▸ | GABRD | O14764 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.33 |
| ▸ | GABRE | P78334 | 1/20 | 0.33 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19398541 | 0.90 | TSHR (0.48) | TSHRPPARDACHETP53TDP1 | |
| SCHEMBL6187009 | 0.87 | TSHR (0.50) | TSHRPPARDACHETP53TDP1 | |
| SCHEMBL7716774 | 0.85 | TSHR (0.48) | TSHRPPARDACHE | |
| SCHEMBL11524014 | 0.84 | TSHR (0.46) | TSHRPPARDACHE | |
| SCHEMBL28583373 | 0.83 | TSHR (0.36) | TSHRPPARDACHEMEN1KMT2A | |
| SCHEMBL15532054 | 0.81 | PPARD (0.47) | TSHRPPARDACHETDP1MEN1 | |
| SCHEMBL7790759 | 0.80 | TSHR (0.41) | TSHRPPARDACHETP53TDP1 | |
| SCHEMBL21828105 | 0.79 | TSHR (0.56) | TSHRPPARDACHETP53TDP1 | |
| SCHEMBL11726422 | 0.78 | PPARD (0.57) | TSHRPPARDACHETP53TDP1 | |
| SCHEMBL9359445 | 0.78 | ACHE (0.39) | TSHRPPARDACHETP53TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4641695-A1 | ELECTROCHEMICAL APPARATUS AND ELECTRONIC DEVICE | Dongguan Amperex Technology Limited (CN) | 2025-10-29 | — | — | EP | claimed |
| US-20230378539-A1 | SECONDARY BATTERY, METHOD FOR PREPARING SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRICAL APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2023-11-23 | — | — | US | claimed |
| EP-4276964-A1 | SECONDARY BATTERY, METHOD FOR PREPARING SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND POWER CONSUMPTION APPARATUS | Contemporary Amperex Technology Co., Limited (CN) | 2023-11-15 | — | — | EP | claimed |
| EP-3035916-B1 | PHARMACEUTICAL COMPOSITION AND USE OF DIETHYL (2-CYANOETHYL)PHOSPHONATE | OLATEC THERAPEUTICS LLC (US) | 2020-06-24 | — | — | EP | claimed |
| CN-105636578-B | The purposes of pharmaceutical composition and (2- cyanoethyl) diethyl phosphonate | 欧拉泰克治疗有限责任公司 | 2019-07-05 | — | — | CN | claimed |
| CN-105636578-A | Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate | OLATEC IND LLC | 2016-06-01 | — | — | CN | claimed |
| US-9149488-B2 | Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate | OLATEC INDUSTRIES LLC (US) | 2015-10-06 | — | — | US | claimed |
| US-20150057252-A1 | PHARMACEUTICAL COMPOSITION AND USE OF DIETHYL (2-CYANOETHYL)PHOSPHONATE | OLATEC THERAPEUTICS, INC. | 2015-02-26 | — | — | US | claimed |
| US-20100101651-A1 | POLYMER SOLAR CELLS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-04-29 | — | — | US | claimed |
| EP-4641695-A1 | ELECTROCHEMICAL APPARATUS AND ELECTRONIC DEVICE | Dongguan Amperex Technology Limited (CN) | 2025-10-29 | — | — | EP | disclosed |
| US-20230378539-A1 | SECONDARY BATTERY, METHOD FOR PREPARING SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRICAL APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2023-11-23 | — | — | US | disclosed |
| US-20230378539-A1 | SECONDARY BATTERY, METHOD FOR PREPARING SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRICAL APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2023-11-23 | — | — | US | disclosed |
| EP-4276964-A1 | SECONDARY BATTERY, METHOD FOR PREPARING SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND POWER CONSUMPTION APPARATUS | Contemporary Amperex Technology Co., Limited (CN) | 2023-11-15 | — | — | EP | disclosed |
| EP-4276964-A1 | SECONDARY BATTERY, METHOD FOR PREPARING SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK, AND POWER CONSUMPTION APPARATUS | Contemporary Amperex Technology Co., Limited (CN) | 2023-11-15 | — | — | EP | disclosed |
| US-5731352-A | THERAPY FOR DISORDERS OF THE MELATONINERGIC SYSTEM | ADIR ET COMPAGNIE (FR) | 1998-03-24 | — | — | US | disclosed |
| EP-0315399-B1 | Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same | RHONE POULENC RORER INT (US) | 1996-01-10 | — | — | EP | disclosed |
| US-5059610-A | QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-22 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
| US-4278791-A | CORROSION RESISTANCE, WETTING AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1981-07-14 | — | — | US | disclosed |
| US-4151229-A | Process for the manufacture of aminoalkyl-phosponic acid esters | CIBA-GEIGY CORPORATION (US) | 1979-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150057252-A1 | PHARMACEUTICAL COMPOSITION AND USE OF DIETHYL (2-CYANOETHYL)PHOSPHONATE | PHOSPHO1, NAPEPLD, P2RY6 | TSHR 4752/4885PPARD 993/4885ACHE 147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.